12 Information Technology Stocks Moving In Friday’s Intraday Session
Gainers AEye (NASDAQ:LIDR) shares increased by 27.6% to $3.56 during Friday’s regular session. The market value of their…
12 Information Technology Stocks Moving In Wednesday’s Pre-Market Session
Gainers Monday.Com (NASDAQ:MNDY) shares rose 19.2% to $216.75 during Wednesday’s pre-market session. The company’s market cap stands at…
Top 4 Tech Stocks You May Want To Dump In Q2
As of April 30, 2024, four stocks in the information technology sector could be flashing a real warning…
12 Information Technology Stocks Moving In Monday’s Intraday Session
Gainers Bit Origin (NASDAQ:BTOG) shares rose 30.7% to $4.34 during Monday’s regular session. The market value of their…
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply in today’s pre-market trading following first-quarter results. Tesla posted weaker-than-expected earnings…
12 Information Technology Stocks Moving In Wednesday’s Pre-Market Session
Gainers Zapata Computing Holdings (NASDAQ:ZPTA) stock increased by 19.9% to $1.87 during Wednesday’s pre-market session. The company’s market…
12 Information Technology Stocks Moving In Tuesday’s After-Market Session
Gainers XIAO-I (NASDAQ:AIXI) stock moved upwards by 8.9% to $1.47 during Tuesday’s after-market session. The market value of…
12 Information Technology Stocks Moving In Tuesday’s Intraday Session
Gainers Cyngn (NASDAQ:CYN) stock rose 58.2% to $0.19 during Tuesday’s regular session. The market value of their outstanding…
Earnings Scheduled For April 23, 2024
Companies Reporting Before The Bell
• RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion.
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.